[
    [
        {
            "time": "2018-02",
            "original_text": "[超配评级]医药行业2018年2月投资策略：踏雪寻成长 回首看龙头",
            "features": {
                "keywords": [
                    "医药行业",
                    "投资策略",
                    "龙头"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "[超配评级]医药行业2018年2月投资策略：踏雪寻成长 回首看龙头",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-02",
            "original_text": "[优异评级]医药生物行业研究简报：改革完善仿制药供应保障 发布全科医生培养与使用文件",
            "features": {
                "keywords": [
                    "医药生物",
                    "仿制药",
                    "全科医生",
                    "政策"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "[优异评级]医药生物行业研究简报：改革完善仿制药供应保障 发布全科医生培养与使用文件",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-02",
            "original_text": "[买入评级]乐普医疗(300003)事件点评：业绩符合预期 心血管+肿瘤双平台齐头并进",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "心血管",
                    "肿瘤",
                    "业绩"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入评级]乐普医疗(300003)事件点评：业绩符合预期 心血管+肿瘤双平台齐头并进",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018",
            "original_text": "[INCREASE评级] CHUANCAI RESEARCH 2018 STRATEGY REPORT：2018 CHINA EQUITY MARKET PHARMACEUTICAL OUTLOOK",
            "features": {
                "keywords": [
                    "CHUANCAI RESEARCH",
                    "2018",
                    "STRATEGY REPORT",
                    "PHARMACEUTICAL OUTLOOK"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "[INCREASE评级] CHUANCAI RESEARCH 2018 STRATEGY REPORT：2018 CHINA EQUITY MARKET PHARMACEUTICAL OUTLOOK",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        }
    ]
]